Antioxidants and immunomodulatory effect of black cumin seed oil in at-risk metabolic syndrome

Akrom Akrom , Endang Darmawan, Nuril Maulida, Syuhada Syuhada

Akrom Akrom
Department of Clinical Pharmacy, Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia ; Ahmad Dahlan Drug Information and Research Center, Universitas Ahmad Dahlan, Yogyakarta, Indonesia. Email: akrom@pharm.uad.ac.id

Endang Darmawan
Department of Clinical Pharmacy, Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia

Nuril Maulida
Graduate Student, Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia

Syuhada Syuhada
Graduate Student, Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
Online First: December 28, 2021 | Cite this Article
Akrom, A., Darmawan, E., Maulida, N., Syuhada, S. 2021. Antioxidants and immunomodulatory effect of black cumin seed oil in at-risk metabolic syndrome. Bali Medical Journal 10(3): 1042-1047. DOI:10.15562/bmj.v10i3.2822

Introduction: Black Cumin Seed Oil (BCSO) is a traditional medicine widely used as an antioxidant and immunomodulator. Objective: The purpose of this study is to investigate the effect of dose variation of BCSO (1.5 ml/day versus 3 ml/day) on IL-10 activity and MDA levels in patients at risk of MS at Jetis 1 Public Health Center (J1PHC), Bantul Regency, Yogyakarta, Indonesia.

Methods: We conducted an analytical cross-sectional study. 66 patients at risk of metabolic syndrome (MS) were divided into two groups. In stage 1, group 1 received a 1.5 ml/day dose, and group 2 received 3 ml/day for 20 days. The clinical parameters of MS, IL-10 activity, and MDA levels were measured at the end of the study stages.

Results: The mean activity of IL-10 in the 1.5 ml/day dose group was 4.83 and in the 3 ml/day dose group was 5.49, which showed an increase of around 13.66% (p = 0.300). The mean MDA level in the 1.5 ml/day group was 3.92 ?mol/L, which increased to 4.31 ?mol/L in the 3 ml/day group or approximately 9.95% (p = 0.802). Statistically, IL-10 activity and MDA levels in the two-dose groups did not differ significantly.

Conclusion: The results of this study indicate that the administration of BCSO at doses of 1.5 ml/day and 3 ml/day for 20 days has the same effect on IL-10 activity and MDA levels in patients at risk of MS. 


Almerie MQ, Kerrigan DD. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast. Med Hypotheses [Internet]. 2020;143(May):109883. Available from: https://doi.org/10.1016/j.mehy.2020.109883

van Koppen A, Verschuren L, van den Hoek AM, Verheij J, Morrison MC, Li K, et al. Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model. Cmgh [Internet]. 2018;5(1):83-98.e10. Available from: https://doi.org/10.1016/j.jcmgh.2017.10.001

Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression: Diabetes and COVID-19. Diabetes Metab Syndr Clin Res Rev [Internet]. 2020;14(4):395–403. Available from: https://doi.org/10.1016/j.dsx.2020.04.018

Shabalala SC, Dludla P V., Mabasa L, Kappo AP, Basson AK, Pheiffer C, et al. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomed Pharmacother [Internet]. 2020;131(September):110785. Available from: https://doi.org/10.1016/j.biopha.2020.110785

Strzelak A, Ratajczak A, Adamiec A, Feleszko W. Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: A mechanistic review. Int J Environ Res Public Health. 2018;15(5).

Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: An overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):1–24.

Celik I, Temur A, Isik I. Hepatoprotective role and antioxidant capacity of pomegranate (Punica granatum) flowers infusion against trichloroacetic acid-exposed in rats. Food Chem Toxicol [Internet]. 2009;47(1):145–9. Available from: http://dx.doi.org/10.1016/j.fct.2008.10.020

Moorthy B, Chu C, Carlin DJ. Polycyclic aromatic hydrocarbons: From metabolism to lung cancer. Vol. 145, Toxicological Sciences. Oxford University Press; 2015. p. 5–15.

Wang S-H, Wang Y-Z, Zhang K-Y, Shen J-H, Zhou H-Q, Qiu ELSEVIER X-Y, et al. Effect of superoxide dismutase and malondialdehyde metabolic changes on carcinogenesis of gastric carcinoma. World J Gastroenterol [Internet]. 2005;11(28):4305–10. Available from: www.wjgnet.comhttp://www.wjgnet.com/1007-9327/11/4305.asp

Hadi S, Mirmiran P, Daryabeygi-Khotbesara R, Hadi V. Effect of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress among people with type 2 diabetes mellitus: A randomized, double-blind, placebo controlled trial. Prog Nutr. 2018;20(9):127–33.

Hidayati T, Akrom, Indrayanti, Sagiran. Chemopreventive effect of black cumin seed oil (BCSO) by increasing p53 expression in dimethylbenzanthracene (DMBA)-induced Sprague Dawley rats. Res J Chem Environ. 2019;23(8).

Arjumand S, Shahzad M, Shabbir A, Yousaf MZ. Thymoquinone attenuates rheumatoid arthritis by downregulating TLR2, TLR4, TNF-? IL-1, and NF?B expression levels. Biomed Pharmacother [Internet]. 2019;111(October 2018):958–63. Available from: https://doi.org/10.1016/j.biopha.2019.01.006

Heshmati J, Namazi N. Effects of black seed (Nigella sativa) on metabolic parameters in diabetes mellitus: A systematic review. Vol. 23, Complementary Therapies in Medicine. 2015.

Agustiarini V, Darmawan E. The effects of dosage variation in black cumin seed oil ( Nigella sativa L .) use on HbA1c levels and interleukin-17A expression in patients at risks of metabolic syndrome. 2019;9(2):261–70.

Fajar DR, Akrom, Darmawan E. The influence of black cumin seed oil therapy with dosage of 1.5 mL/day and 3 mL/day to interleukin-21 (IL-21) expression of the patients with metabolic syndrome risk. In: IOP Conference Series: Materials Science and Engineering. 2017.

Ray S, Fitzpatrick S, Golubic R, Fisher S. Oxford Handbook of Clinical and Healthcare Research. Sources bias. 2016;608.

Aulia Rahim A and ED. HbA1c and interleukin-17a level inpatient at risk for metabolic syndrome in Yogyakarta. Res J Chem Environ [Internet]. 2019;23(9):38–42. Available from: https://worldresearchersassociations.com/Archives/RJCE/Vol(23)2019/September2019.aspx

McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clin Dermatol [Internet]. 2018;36(1):14–20. Available from: http://dx.doi.org/10.1016/j.clindermatol.2017.09.004

Llamas-Velasco M, Ovejero-Merino E, Salgado-Boquete L. Obesity — A Risk Factor for Psoriasis and COVID-19. Actas Dermo-Sifiliográficas (English Ed [Internet]. 2021;(xxxx). Available from: http://dx.doi.org/10.1016/j.adengl.2021.03.013

Becerra-Díaz M, Wills-Karp M, Heller NM. New perspectives on the regulation of type II inflammation in asthma. Vol. 6, F1000Research. Faculty of 1000 Ltd; 2017.

Hamdan A, Idrus RH, Mokhtar MH. Effects of nigella sativa on type-2 diabetes mellitus: A systematic review. Vol. 16, International Journal of Environmental Research and Public Health. 2019.

Akrom, Mustofa. Black cumin seed oil increases phagocytic activity and secretion of IL-12 by macrophages. Biomed Res. 2017;28(12).

Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. International Immunopharmacology. 2005.

Hidayati T, Gugun AM. Exercise Habits , Hematogram and Blood Chemistry of Diabetes Mellitus Patients at Risk For Metabolic Syndrome , Bantul Public Health Center. 2020;24(02):475–87.

Herlina, Aziz SA, Kurniawati A, Faridah DN. Changes of Thymoquinone, Thymol, and Malondialdehyde Content of Black Cumin (Nigella sativa L.) in Response to Indonesia Tropical Altitude Variation. HAYATI J Biosci. 2017;24(3):156–61.

Jin P, Cong S. LOX-1 and atherosclerotic-related diseases. Vol. 491, Clinica Chimica Acta. Elsevier B.V.; 2019. p. 24–9.

Hidayati T, Pramono A, Jenie IM, Soesatyo MH. Evaluation of black cumin seeds hexane extract as reactive oxygen intermediates (ROI) and phagocytic activity modulator in DMBA inducedrats. Biomed Res. 2017;28(4):1755–60.

Kulyar MF e. A, Li R, Mehmood K, Waqas M, Li K, Li J. Potential influence of Nagella sativa (Black cumin) in reinforcing immune system: A hope to decelerate the COVID-19 pandemic. Phytomedicine [Internet]. 2020;(April):153277. Available from: https://doi.org/10.1016/j.phymed.2020.153277

Hasanpour M, Iranshahy M, Iranshahi M. The application of metabolomics in investigating anti-diabetic activity of medicinal plants. Biomed Pharmacother [Internet]. 2020;128(March):110263. Available from: https://doi.org/10.1016/j.biopha.2020.110263

Akrom A, Nurfadjrin R, Darmawan E, Hidayati T. Black Cumin Seed Oil Antidiabetogenic by Increasing Pancreatic P53 Expression. Int J Public Heal Sci. 2018;7(3):207.

Sarwar R, Pierce N, Koppe S. Obesity and nonalcoholic fatty liver disease: Current perspectives. Diabetes, Metab Syndr Obes Targets Ther. 2018;11:533–42.

No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0